Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaki Shiota

Showing results (1-10 of 286) with videos related to

Pageof 29
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2016
Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancerMasaki Shiota, Masatoshi Eto
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[The concept and mechanisms of castration-resistant prostate cancer]Seiji Naito, Masaki Shiota
Journal of Molecular Endocrinology|April 21, 2011
Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic targetMasaki Shiota, Akira Yokomizo, Seiji Naito
Free Radical Biology & Medicine|August 9, 2011
Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancerMasaki Shiota, Akira Yokomizo, Seiji Naito
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[The development of therapeutics targeting oxidative stress in prostate cancer]Masaki Shiota, Akira Yokomizo, Seiji Naito
Cancers|September 9, 2022
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current DataLeandro Blas, Masaki Shiota, Masatoshi Eto
Endocrine-Related Cancer|October 4, 2012
Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancerMasaki Shiota, Akira Yokomizo, Seiji Naito
Cancers|June 10, 2022
Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical ProstatectomyMasaki Shiota, Leandro Blas, Masatoshi Eto
Cancer Treatment and Research Communications|July 14, 2022
Current status and future perspective on the management of metastatic castration-sensitive prostate cancerLeandro Blas, Masaki Shiota, Masatoshi Eto
Frontiers in Oncology|January 22, 2016
Taxane Chemotherapy for Hormone-Naïve Prostate Cancer with Its Expanding Role as Breakthrough StrategyMasaki Shiota, Akira Yokomizo, Masatoshi Eto
Pageof 29

Showing results (1-10 of 286) with videos related to

Sort By:
Pageof 29
International Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2016
Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancerMasaki Shiota, Masatoshi Eto
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[The concept and mechanisms of castration-resistant prostate cancer]Seiji Naito, Masaki Shiota
Journal of Molecular Endocrinology|April 21, 2011
Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic targetMasaki Shiota, Akira Yokomizo, Seiji Naito
Free Radical Biology & Medicine|August 9, 2011
Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancerMasaki Shiota, Akira Yokomizo, Seiji Naito
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[The development of therapeutics targeting oxidative stress in prostate cancer]Masaki Shiota, Akira Yokomizo, Seiji Naito
Cancers|September 9, 2022
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current DataLeandro Blas, Masaki Shiota, Masatoshi Eto
Endocrine-Related Cancer|October 4, 2012
Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancerMasaki Shiota, Akira Yokomizo, Seiji Naito
Cancers|June 10, 2022
Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical ProstatectomyMasaki Shiota, Leandro Blas, Masatoshi Eto
Cancer Treatment and Research Communications|July 14, 2022
Current status and future perspective on the management of metastatic castration-sensitive prostate cancerLeandro Blas, Masaki Shiota, Masatoshi Eto
Frontiers in Oncology|January 22, 2016
Taxane Chemotherapy for Hormone-Naïve Prostate Cancer with Its Expanding Role as Breakthrough StrategyMasaki Shiota, Akira Yokomizo, Masatoshi Eto
Pageof 29